Lonza

Company Overview

Lonza is a manufacturing organization that serves pharmaceutical, biotech, and nutrition companies. It operates in four business divisions: biologics, cell and gene, small molecules, capsules, and health ingredients. Lonza offers services and products that support the customers’ pre-clinical to commercial-stage manufacturing needs. It provides its CDMO services and products to more than 770 customers across five continents. In the cell and gene segment, Lonza offers services including process development, cGMP manufacturing, regulatory consulting, bioassay services, and tissue acquisition. It has a total of six cell and gene manufacturing locations: three located in the U.S., two in Europe, and one in Asia.

Financial Highlights (FY 2025)

Company's Business Segments

• Integrated Biologics : This segment helps to accelerate and de-risk the path to market with best-in-class, end-to-end offerings from clinical development to drug substance and drug product manufacturing. It also comprises two Technology Platforms: Mammalian and Drug Product.
• Advanced Synthesis : This segment comprises two technology platforms such as bioconjugates and small molecules leveraging new and established modalities to enable advanced therapies for its customers and their patients.
• Specialized Modalities : This segment provides comprehensive solutions that facilitate the accelerated development, manufacturing, and commercialization of life-changing treatments.